Generic Name and Formulations:
Neisseria meningitidis recombinant proteins 50mcg each of Neisserial adhesin A (NadA), Neisserial Heparin Binding Antigen (NHBA), and factor H binding protein (fHbp), 25mcg of Outer Membrane Vesicles (OMV); per 0.5mL; susp for IM inj.
Indications for BEXSERO:
Meningitis B immunization.
Adults and Children:
<10yrs: not established. Give by IM inj in deltoid muscle of upper arm. 10–25yrs: 2 doses (0.5mL each) given at least 1 month apart.
Severe allergic reaction after a previous dose of Bexsero.
May not protect against all meningococcal serogroup B strains. Have epinephrine inj available. Immunosuppressed. Latex allergy. Elderly. Pregnancy (Cat.B). Nursing mothers.
Concomitant other vaccines: see full labeling.
Inj site pain, myalgia, erythema, fatigue, headache, induration, nausea, arthralgia; syncope.
To register women who receive Bexsero during pregnancy call (877) 683-4732.
Single-dose prefilled syringes—1, 10
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Rapid Cycling Bipolar Disorder Associated With ADHD and Female Gender
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Symptom Trajectories Vary According to Language Development in Autism
- Quetiapine Exposure Does Not Appear to Increase Risk for Infant Malformations
- Selective Serotonin Reuptake Inhibitors May Increase Risk for Suboptimal Fetal Growth
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Prenatal Insecticide Exposure in Mother May Be Linked to Risk for Autism in Children